Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OSO BioPharmaceuticals Manufacturing | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

OSO BioPharmaceuticals Manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identify new business opportunities and develop strategies to meet the organization’s long-term business objectives. OSO BioPharmaceuticals is located in Albuquerque, NM at the site formerly owned by Catalent Pharma Solutions.
      
“Rick is a seasoned business development and operations executive with over 25 years of experience in biotechnology and pharmaceutical companies. His distinguished track record in the industry and extensive experience will be an invaluable resource to the company and broadens the executive management team at an important stage in the growth of our business,” said Milton Boyer, vice president of business development and sales for OsoBio. “We are pleased to welcome Rick to the OsoBio team.”

Prior to joining the company, Mr. Lapointe served as head of contract manufacturing at HollisterStier Laboratories and director of manufacturing at Bayer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters